Shalini Bhattacharya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shalini Bhattacharya has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Anna Tröger
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, The Netherlands
1 shared publication- Carmen Goicoechea
Department of Social, Work and Differential Psychology, Complutense University of Madrid, Madrid, Spain
1 shared publication Clara Miguel
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, The Netherlands
1 shared publication- Joseph K. Carpenter
VA Boston Medical Center
1 shared publication Mark Kennedy
Institute of Psychiatry, Psychology & Neuroscience - King's College London, United Kingdom
1 shared publicationPim Cuijpers
Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health research institute, Vrije Universiteit Amsterdam, the Netherlands; Babeș-Bolyai University, International Institute for Psychotherapy, Cluj-Napoca, Romania
1 shared publication
Latest Publications
- Open Access
- 13 January 2023
- Published by Elsevier in Journal of Affective Disorders
- Vol. 325, 572-581
Effect of psychotherapy for adult depression on self-esteem: A systematic review and meta-analysis
- 13 January 2023
- Published by Elsevier in Journal of Affective Disorders
- Vol. 325, 572-581
Open AccessEffect of psychotherapy for adult depression on self-esteem: A systematic review and meta-analysis
- Open Access
- 19 December 2022
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 25 (1) , 19-30
Efficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Meta-Analysis of Recent Literature
Purpose of Review: Effective treatment of anxiety-related disorders is crucial, considering the prevalence of such disorders and their association with poor psychosocial functioning. To evaluate the most recent evidence on the efficacy of cognitive behavioral therapy (CBT) for anxiety-related disorders in adults, we conducted a meta-analysis of randomized placebo-controlled trials published since 2017. Recent Findings: Ten studies with a total of 1250 participants met the inclusion criteria. Seven of these studies examined PTSD. The findings demonstrated small placebo-controlled effects of CBT on target disorder symptoms (Hedges’ g = 0.24, p < 0.05) and depression (Hedges’ g = 0.15, p = n.s). When examining only PTSD studies, effects were reduced (Hedges’ g = 0.14, p < 0.05). Heterogeneity in most analyses was very low, and no publication bias was found. Summary: Effect sizes from placebo-controlled trials from the past 5 years appear to be smaller than those in prior meta-analyses. The findings are largely driven by research on PTSD, with few placebo-controlled trials of other anxiety-related disorders published since 2017.
- 19 December 2022
- Published by Springer Nature in Current Psychiatry Reports
- Vol. 25 (1) , 19-30
Open AccessEfficacy of Cognitive Behavioral Therapy for Anxiety-Related Disorders: A Meta-Analysis of Recent Literature
Purpose of Review: Effective treatment of anxiety-related disorders is crucial, considering the prevalence of such disorders and their association with poor psychosocial functioning. To evaluate the most recent evidence on the efficacy of cognitive behavioral therapy (CBT) for anxiety-related disorders in adults, we conducted a meta-analysis of randomized placebo-controlled trials published since 2017. Recent Findings: Ten studies with a total of 1250 participants met the inclusion criteria. Seven of these studies examined PTSD. The findings demonstrated small placebo-controlled effects of CBT on target disorder symptoms (Hedges’ g = 0.24, p < 0.05) and depression (Hedges’ g = 0.15, p = n.s). When examining only PTSD studies, effects were reduced (Hedges’ g = 0.14, p < 0.05). Heterogeneity in most analyses was very low, and no publication bias was found. Summary: Effect sizes from placebo-controlled trials from the past 5 years appear to be smaller than those in prior meta-analyses. The findings are largely driven by research on PTSD, with few placebo-controlled trials of other anxiety-related disorders published since 2017.